Emmanuel B. Babin
Caen, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
Factors for pain in office-based voice implant replacement. A multicenter prospective GETTEC study.
Journal: European annals of otorhinolaryngology, head and neck diseases
Published: December 07, 2025
Characteristics and performance of the new assessment method during the national digital interfaculty practice exams for the second cycle of medical education
Journal: La Revue de medecine interne
Published: October 05, 2025
Innovative screening for OSAS in patients with head and neck cancer using the apneal application: Protocol for a prospective single-centre study.
Journal: PloS one
Published: October 03, 2025
The price of success in surgery.
Journal: European annals of otorhinolaryngology, head and neck diseases
Published: October 01, 2025
French campaign for laryngectomees' quality of life.
Journal: European annals of otorhinolaryngology, head and neck diseases
Published: September 27, 2025
Social health at 5 years after diagnosis of head and neck cancer.
Journal: Oral oncology
Published: July 01, 2025
Regional Disparities in Head and Neck Cancer Management: A Global Cross-Sectional Survey of the World Federation of ENT Societies.
Journal: Head & neck
Published: June 09, 2025
Return to work, after head and neck cancer: results from the French VICAN study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 18, 2025
Use of patient-derived tumor organoids from head and neck squamous cell carcinoma for the evaluation of the differential effect of carbon ions over X-rays.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 31, 2025
The International Francophone ENT Society (SIFORL): A dynamic and ambitious society.
Journal: European annals of otorhinolaryngology, head and neck diseases
Published: December 12, 2024
Treatment of epistaxis in Osler-Weber-Rendu disease by bevacizumab nasal spray. The EROSB study: Determining the effective dose.
Journal: European annals of otorhinolaryngology, head and neck diseases
Published: November 07, 2024
Last Updated: 09/26/2026